WonderTx
New accelerator entry · 2026-08-13 · the record
In their words
We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery. This should dramatically increase our probability of success. There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.
What the record says
Founder and CEO of A Company in Stealth Mode. Previously, cofounded Atomwise, the first company to deploy deep learning for structure-based drug design ($220+ million in funding; 100 hires; signed $5B in total partnership value with Sanofi, Bayer, Eli Lilly, etc; ran largest AI-driven drug discovery experiment w/ 600+ researchers in 30 countries). Even more previous: PhD @ U of Toronto; inventor on 15 patents + applications; IBM Research; AI for Cornell’s world champion robotic soccer team.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
Against the 209 companies on file from Summer 2026. Median team 2, largest 30.
The nearest companies on file from the same batch, side by side with this one.
| Company | Batch | Sectors | Listed |
|---|---|---|---|
| Frontier Computing | Summer 2026 | Artificial Intelligence, Hard Tech, Hardware | 2026-08-31 |
| Ethos Space Resources | Summer 2026 | Hard Tech, Exascale Computing, Energy | 2026-08-23 |
| Spectre Intelligence | Summer 2026 | Biotech, Investing, Trading | 2026-08-22 |
| Edgerun | Summer 2026 | Robotics, Defense | 2026-08-21 |
| Allia Health | Summer 2026 | Artificial Intelligence, Healthcare, Mental Health | 2026-08-19 |
| WonderTx (this page) | Summer 2026 | AI-powered Drug Discovery, Generative AI, Biotech | 2026-08-13 |
Click a column heading to sort. Comparison is against records held here, not against every company that exists.
The full profile
The rest of this profile is open on any paid or trial plan
It costs no credits. It is a plan check and nothing else.
- Source Check — verify Abraham Heifets's other claims against the registers that hold them.
- INVEST — compare this company against the peers above, on the numbers.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Abraham Heifets for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist WonderTxYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind WonderTx: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry. Figures are read directly from the source record; names have not been matched against other people.